The GP2A (Group for the Promotion of Pharmaceutical chemistry in Academia) is delighted to announce the 34th GP2A 2026 Conference on Medicinal Chemistry, hosted by the Department of Chemistry and Molecular Biology at the University of Gothenburg, Sweden, 26–28 August 2026. The Conference is organized in collaboration with the SIGMA-1 Europe Cost Action (https://sigma1europe.eu/)

The conference venue is the brand-new Natrium Research Building, a state-of-the-art facility in the Faculty of Science and Technology.

Confirmed Keynote Speakers

• Mark Brönstrup, Helmholtz Centre for Infection Research, Germany
• Magnus J. Johansson, AstraZeneca & Stockholms Universitet, Sweden
• Silvia Ortega Gutiérrez, Universidad Complutense de Madrid, Spain
• Maria Duca, CNRS Université Côte d’Azur, France
• Matt Todd, University College London, United Kingdom
• Laurence Lafanechère, Saxol & CNRS Université Grenoble Alpes, France
• Nina Hartrampf, University of Zurich, Switzerland
• Tangui Maurice, CNRS, INSERM U1198, France
• Carmen Abate, Università Degli Studi Di Bari, Italy
• Johannes Broichhagen, Leibniz Research Institute for Molecular Pharmacology, Germany
• Ed Tate, Imperial College London, UK

…and more to come.

Confirmed Scientific Sponsor Presentation

• Alexander Neumann, BioSolveIT, Germany

Preliminary Program: Will be published soon.

Flyer: Available here.

Read more on the conference website: GP2A 2026.